XSS in Bmc Remedy Mid-Tier
CVE-2017-17678
BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.
Vulnerability class: XSS (Cross-Site Scripting)
Published · last modified .
CVSS v3 metric
CVSS v3 base score 6.1 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N.
EPSS exploit prediction
EPSS 0.006, 48.8th percentile (scored ); unchanged over 30 days. About EPSS.
Affected products
- Bmc Remedy Mid-Tier — versions 9.1
Weakness classification (CWE)
References
- bmc.com (Product)
- remedy.com (Product)
- docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security… (Release Notes, Vendor Advisory)
- seclists.org/fulldisclosure/2017/Oct/52 (Mailing List, Third Party Advisory)